Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03884556
Title TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tizona Therapeutics, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Cancer Center Orange California 92868 United States Details
UC Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Nebraska Cancer Center Oncology Hematology West P.C. Omaha Nebraska 68130 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44122 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
West Cancer Center and Research Institute Germantown Tennessee 38138 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Huntsman Cancer Intitute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field